Medscape

Clinical Concerns: Insulin Delivery System Sensors

This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
Nasdaq

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes

LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
FierceBiotech

Dexcom finally ties up long-awaited G7 diabetes sensor clearance after FDA resubmission

Dexcom is in seventh heaven: A year after its initial FDA submission, the diabetes tech maker has finally gotten the green light to begin rolling out its latest continuous glucose monitor system in ...
Nasdaq

DexCom (DXCM) Launches Latest CGM Sensor ONE in France

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...
Monthly Prescribing Reference

FDA: Dexcom G5 CGM System Can Replace Fingerstick Testing in T2DM Management

The Food and Drug Administration (FDA) has expanded the use of Dexcom's G5 Mobile Continuous Glucose Monitoring (CGM) System to allow for replacement of blood glucose testing for diabetes treatment ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...